Daily Dispatch

The 'Dispatched' Podcast

News EN ↓ 209 episodes

BioPharmaDispatch - discussing the issues impacting the Australian biopharmaceutical and life sciences sectors with Paul Cross and Felicity McNeill.

Be sure to visit the podcast's website and support the creator: bpd.captivate.fm

Author

Daily Dispatch

Category

News

Podcast website

bpd.captivate.fm

Latest episode

Nov 13, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

The 'Week in Review' - 21 June 21.06.2024

The new Community Pharmacy Agreement is a remarkable document. We explain why it should be read and the negotiation analysed. We also discuss the draft National Immunisation Strategy, the events in New Zealand, and whether we can extract ourselves from a policy discussion that is mostly about health financing. 

The 'Week in Review' - 13 June 13.06.2024

It's a 'swear jar' episode we discuss the obsession with health technology assessment, why it is used to guide what is just price negotiation, meaning it takes too long, how decision-makers subordinate patient needs to this negotiation, what the future could look like and how it might get even worse.

The 'Week in Review' - 7 June 07.06.2024

Budget Estimates and officials acknowledge the slow uptake of 60-day prescriptions. The 'professionally edited' HTA review final report is with the minister, more evidence of the need to watch the diabetes tender and the need for action to ensure the legitimacy of Australia's new National Immunisation Strategy.

The 'Week in Review' - 31 May 31.05.2024

The deeper issue revealed by the failure to consult on Australia's new National Immunisation Strategy. One year on from the health minister's admission that people die waiting for access to health technologies and disappointment for patients in New Zealand.

The 'Week in Review' - 24 May 24.05.2024

We discuss the BPD Annual Conference, our favourite speakers and panels, including Pharmacy Guild National President Professor Trent Twomey and Dr Ian Watt AC, and the focus on women's health and New Zealand.  Why we should encourage more straight-talking and the connectivity that links so many different parts of the health system.

Can we just have an honest conversation about Budget and reform realities? 19.05.2024

Rather than dismissing Budget realities, stakeholders could be invited into the Government's confidence and told to prepare for a mature conversation about the challenge of funding the PBS and a serious reform agenda to facilitate faster access to health technologies as Australia enters a period of serious fiscal consolidation.

The 2024-25 Budget Review 14.05.2024

Patients and pharmacies are the winners, but the Budget raises more questions than it answers, with a large Contingency Reserve and what appears to be a raft of decisions taken but not announced.

Budget Week Preview - 12 May 12.05.2024

Budget week is upon us. We share our experiences working on Budgets and discuss the behind-the-scenes process Governments undertake to develop their major annual set-piece announcement. Budgets have changed over the years with the increasing use of 'hidden' measures - which is why caution is required. Who should be telling who about communicating with patients?

The 'Week in Review' - 3 May 03.05.2024

Some important messages and learnings from this week's 'Valuing Life—Medicines Access Summit' in Wellington, with patients and clinicians leading with a straight-talking critique of decision-making that has clearly resonated with New Zealand's political leaders.

The 'Week in Review' - 26 April 28.04.2024

The importance of scrutinising claims involving data, particularly regarding health care, and the double standard regarding productivity. Kudos to a company for welcoming a new listing but calling out that it has taken over 650 days since TGA registration. The challenge of social media for vulnerable communities.

The 'Week in Review' - 19 April 19.04.2024

The 2024-25 Budget is fast approaching. We discuss what to look for, where to exercise caution, and what to ignore.  More examples of where informing is confused with consulting leading to the problematic implementation of reform.

The 'Week in Review' - 12 April 12.04.2024

The health department is allowing employees to vote on a new name for its main building. We have some suggestions. Is our health system capable of learning from patient experience and the challenges many severely immunocompromised patients face battling to access treatments and immunisation?

The 'Week in Review' - 5 April 04.04.2024

This is a podcast without any mention of that HTA Review! Delegated decision-making is a significant feature of Australia's health system. How can advocacy and any push for change be effective without understanding how delegation works? The reality is that when a minister delegates a decision-making power, they formally remove themselves from the decision.

The 'Week in Review' - 22 March 21.03.2024

Where do we start? Last year, the minister described Australia's HTA decision-making as clunky and agreed that it led to unnecessary deaths. How does that admission sit with his latest appointments? We start putting together the pieces of a worrying puzzle and constructing a timeline.  

The 'Week in Review' - 15 March 14.03.2024

The Albanese Government has committed an additional $3 billion for the new Community Pharmacy Agreement. The details are yet to come, but the statement and confirmed financial commitment reflect a Cabinet-endorsed Budget decision. Health Minister Mark Butler said he would now engage with "other stakeholders with an interest in the pharmacy sector to finalise separate arrangements". What...

The 'Week in Review' - 8 March 06.03.2024

We discuss speculation surrounding the new Community Pharmacy Agreement and why successive governments support the framework approaching its 35th year. Community pharmacies are a good partner for the government, and so is the industry, but for a very different reason. We also urge the industry to be true to its stated commitment to patients and publicly explain its concerns about the HTA review op...

The 'Week in Review' - 1 March 01.03.2024

The industry must be congratulated for firming up its criticism of the HTA Review options paper, and it should start speaking publicly about its concerns. The history and how agreements with the federal government have evolved over time. Another disappointment on newborn screening.

The 'Week in Review' - 23 February 23.02.2024

Nothing frustrates an advisory committee more than the word 'advisory'.  Why any extended powers will be used to their full extent and not in the way many people would like.

The 'Dispatched Podcast' - 21 February 20.02.2024

The consultation process for the HTA Review options paper upfront invalidates the input of companies, patients and clinicians with an unprecedented 'declaration' process that defines any relationship or expression of a lived experience as a conflict.

The 'Week in Review' - 16 February 16.02.2024

It was not an easy or enjoyable decision, but the stakes are very high for Australian patients, given the apparent risks to the future of funded access to health technologies. We also discuss Senate Estimates, a new argument to excuse non-action on newborn screening, Medicare bulk-billing and teddy bears, and the right to disconnect.

HTA Review options paper interview - 31 January 13.02.2024

With just nine days remaining for stakeholders to submit their feedback on the Health Technology Assessment Review options paper, patients must have access to all pertinent information. BioPharmaDispatch interviewed Medicines Australia chief executive and reference committee member Liz de Somer on 31 January. The interview was published on 1 February . Medicines Australia approved all included quo...

The 'Week in Review' - 9 February 09.02.2024

The 'Swiss cheese' theory might explain why history is constantly repeating itself and why action is required to avoid the worst aspects of the proposals in the HTA Review options paper.

The 'Week in Review' - 2 February 02.02.2024

We are back for 2024 with no end of issues to discuss, starting with the HTA review options paper and the coincidence of many reviews and processes delivering outcomes just ahead of the May Budget.

The 'End of Year Review' - 19 December 18.12.2023

Looking ahead, the industry needs to find a framework for challenging the government on its decision-making, and awards that recognise the bad, the ugly and the good in 2023. Timeline 0:00 - 12:00 - Why the industry needs to find a framework for challenging the government in its decision-making. Awards 12:00 - 17:00 - 'We definitely seriously want to improve transparency and accountability bu...

The 'Week in Review' - 8 December 08.12.2023

More silence on a critical social issue. The report of the NDIS review delivers a range of recommendations, including the adoption of an evidence-based funding framework, but is it practical or even possible? Some interesting comments from NDIS minister Bill Shorten might open the door for advocates of health system reform, a debate that always comes down to a question of health system financing.

Listen to the The 'Dispatched' Podcast podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.